Analyst firms · Wolfe Research · IMVT
Wolfe Research IMVT price target and rating history
Immunovant Inc. (IMVT) · Health Care
Wolfe Research rates Immunovant Inc. (IMVT) Outperform with a $50 price target, as of its latest action on Jan 6, 2026. It has published 3 rating actions on IMVT since February 2024, including 1 upgrade and 1 downgrade.
- Current rating
- Outperform
- Price target
- $50
- Median target, all firms
- Too few
- Actions on IMVT
- 3
Wolfe Research price target on IMVT
Every Wolfe Research rating on IMVT
- Jan 6, 2026
- Jan 3, 2025
- Feb 15, 2024
How other firms rate IMVT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Mkt Perform | $28 | Mar 20, 2026 |
| Wolfe Research | Outperform | $50 | Jan 6, 2026 |
Questions about Wolfe Research and IMVT
- What is Wolfe Research's price target for IMVT?
- Wolfe Research's latest stated price target for Immunovant Inc. (IMVT) is $50, from its action on Jan 6, 2026.
- What is Wolfe Research's rating on IMVT?
- Wolfe Research rates IMVT Outperform, a bullish rating, as of Jan 6, 2026.
- When did Wolfe Research last change its view on IMVT?
- On Jan 6, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $50.
All Wolfe Research ratingsIMVT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.